New York, NY -- (SBWIRE) -- 12/19/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding DepoMed Inc. (NASDAQ:DEPO) and Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA).
DepoMed Inc. (NASDAQ:DEPO) a specialty pharmaceutical company that focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States closed up in its previous session (+17.60%) on 3,169,063 shares traded after Depomed Acquired CAMBIA Migraine Medicine from Nautilus Neurosciences for $48.7 Million. DepoMed Inc. (NASDAQ:DEPO) is currently up (+98%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about DepoMed Inc. (NASDAQ:DEPO)
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) a biotechnology company that engages in the development of small molecule drugs for the infectious disease areas closed down in its previous session (-22.13%) on 1,156,487 shares traded after ENANTA PHARMACEUTICALS INC Filed SEC form 10-K, Annual Report. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is currently down (-28.22%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)